Zantac Update: FDA Recalls All Ranitidine From Market
On Wednesday, April 1, 2020, the U.S. Food and Drug Administration requested that manufacturers recall all prescription and OTC ranitidine drugs from the market immediately. The agency has determined that an impurity increases over time, particularly in warm storage temperatures, resulting in unacceptable exposure to the carcinogen NDMA. While some samples tested did not contain…